Suggested links

Mesothelioma Survival Rate

A survival rate describes the percentage of patients who are alive after a certain period of time following their diagnosis. About 12% of patients with mesothelioma will still be alive 5 years after being diagnosed with this cancer. The best way to live longer with mesothelioma is to get treated. Learn how you can access treatments that could improve your survival rate.

Medically reviewed by: Mark Levin, MD

Last updated:

What Is the Survival Rate of Mesothelioma?

Survival rate is the percentage of mesothelioma patients still alive for months or years after diagnosis. This rate is part of a patient’s mesothelioma prognosis their projected health outcome following diagnosis.

That said, survival rates can vary greatly depending on your mesothelioma type, the cancer treatments you receive, and many other factors.

Is Mesothelioma Survival Rate the Same Thing as Life Expectancy?

A mesothelioma doctor explains mesothelioma survival rate to his patient

No. Mesothelioma life expectancy is the estimated time a patient is projected to live. It’s typically measured in years or months. The average mesothelioma life expectancy is 12-21 months.

Survival rate refers to the percentage of patients who live past a set amount of time following their diagnosis. It’s also a different metric from the mesothelioma mortality rate, which is the number of patients who have died after a set period of time.

How Long Can You Live With Mesothelioma?

The chart below shows mesothelioma survival rates at 1, 3, and 5 years.

Time After Mesothelioma DiagnosisSurvival Rate
1 year43.7%
3 years16.8%
5 years12%
Source: National Cancer Institute (NCI) SEER Database and ASCO

Since long-term mesothelioma survival rates are often poor, it can be scary to think about them. However, a survival rate is just an average, and you may be able to become a survivor with proper treatment.

Learn about mesothelioma patients who have gone on to live for 15+ years after being diagnosed in our Free Survivors Guide.

Mesothelioma Survivors Guide
Get Your Free Survivors Guide
  • Survivors who beat the odds
  • Tips for fighting mesothelioma
  • Navigating life after treatment

Get It Shipped Overnight

Survival Rates for Each Type of Mesothelioma

What type of mesothelioma someone has can greatly affect how long they live. Some types of mesothelioma are easier to treat than others. Thus, survival rates differ by each type.

Pleural Mesothelioma Survival Rate

Malignant pleural mesothelioma, which develops in the lining of the lungs (pleura), is the most common type of mesothelioma. However, its long-term survival rates are lower when compared to some of the other types of this cancer.

The chart below shows key pleural mesothelioma survival data.

Time After DiagnosisSurvival Rate
1 year73%
3 years23%
5 years12%
10 years5%
Source: Moffitt Cancer Center

Pleural mesothelioma survival figures have been steadily increasing thanks to treatment breakthroughs, according to a 2022 report from Heidelberg University Hospital researchers.

Get access to top doctors who can help increase your survival time with our Free Mesothelioma Doctor Match.

Peritoneal Mesothelioma Survival Rate

Malignant peritoneal mesothelioma develops in the lining of the abdomen (peritoneum) and generally has the best prognosis compared to other types of mesothelioma.

View peritoneal mesothelioma cancer survival rates in the chart below.

Time After DiagnosisSurvival Rate
1 Year92%
3 Year74%
5 Year65%
10 Year39%
Source: Moffitt Cancer Center

Peritoneal mesothelioma is much easier to treat than pleural mesothelioma, so these patients have better survival rates.

Pericardial Mesothelioma Survival Rate

Pericardial mesothelioma is a very rare form of this cancer. It forms in the heart’s lining and has arguably the worst survival rates of any type of mesothelioma.

Time After DiagnosisSurvival Rate
1 year26%
3 years14%
5 years9%
Source: Moffitt Cancer Center

Testicular Mesothelioma Survival Rate

Testicular mesothelioma develops in the lining of the testicles. It’s the rarest type of this cancer, but patients have relatively good long-term survival rates.

Time After Diagnosis
Survival Rate
5 Years49%
10 Years33%
Source: Urology (2019)

You may be able to improve your survival rate with treatment from a mesothelioma specialist. Use our Free Doctor Match to find surgeons and oncologists near you.

Mesothelioma doctor talking with an older couple
Free Mesothelioma Doctor Match

We'll help you connect with a local mesothelioma specialist for personalized treatment.

Find a Doctor Near You

Mesothelioma Survival Rates By Stage

Mesothelioma staging is one of the most useful ways to break down survival rate data. The stage of mesothelioma refers to how far the cancer has spread within the body by the time of diagnosis.

Pleural mesothelioma is the only type of this cancer with a staging system.

The following charts show pleural mesothelioma life expectancy and survival rates by stage when treated with surgery.

Pleural Mesothelioma Stage 1
Life Expectancy19.2 months
2-Year Survival Rate39%
5-Year Survival Rate11%
Source: National Cancer Database (NCDB) (August 2022)
*Note: NCDB data indicates no difference in survival rates between Stage 1 and Stage 2.
Pleural Mesothelioma Stage 2
Life Expectancy19.2 months
2-Year Survival Rate39%
5-Year Survival Rate11%
Source: National Cancer Database (NCDB)(August 2022)
*Note: NCDB data indicates no difference in survival rates between Stage 1 and Stage 2.
Pleural Mesothelioma Stage 3
Life Expectancy18.9 months
2-Year Survival Rate41%
5-Year Survival Rate13%
Source: National Cancer Database (NCDB) (August 2022)
Pleural Mesothelioma Stage 4
Life Expectancy13.1 months
2-Year Survival Rate31%
5-Year Survival Rate11%
Source: National Cancer Database (NCDB) (August 2022)

If metastasis (when cancer spreads to other parts of the body) has occurred in the later stages, a patient’s overall survival rate will be lower as the cancer is harder to treat.

Survival Rate by Mesothelioma Cell Type

Mesothelioma tumors can be made up of different types of cells. Because some of these cells respond better to treatment than others, cell type also impacts the survival rate.

Epithelioid is the most common and easiest to treat, so patients with epithelial mesothelioma often live longer than patients with other cell types. Sarcomatoid mesothelioma cells tend to spread rapidly through the body and do not respond well to treatment, so survival rates are poor.

Epithelioid Mesothelioma Survival*
2-Year Survival Rate45%
5-Year Survival Rate14%
Source: NCDB (2022)
*When treated with surgery
Sarcomatoid Mesothelioma Survival*
2-Year Survival Rate15%
5-Year Survival Rate4%
Source: NCDB (2022)
*When treated with surgery

Biphasic mesothelioma tumors contain both epithelioid and sarcomatoid cells. Patients with biphasic mesothelioma may live longer if more epithelial cells are present.

Biphasic Mesothelioma Survival*
2-Year Survival Rate22%
5-Year Survival Rate5%
Source: NCDB (2022)
*When treated with surgery

Mesothelioma Survival Rates By Patient Demographics

Most mesothelioma patients are men over the age of 65. However, anyone can develop mesothelioma, and some demographic factors can help or hinder survival.

The charts below show how sex, age, and race affect survival rates for mesothelioma.


Though mesothelioma mainly affects men, women with mesothelioma tend to live longer.

Survival RateMaleFemale
1-Year Survival Rate41.3%51%
2-Year Survival Rate21.3%33.8%
3-Year Survival Rate13.6%26.5%
4-Year Survival Rate10.1%21.9%
5-Year Survival Rate8.0%18.8%
Source: NCI SEER Database


Older patients have a lower survival rate than younger mesothelioma patients.

Younger patients are typically in good overall health and respond better to treatment, such as aggressive surgeries that can help them live longer.

Age GroupOverall Survival Rate
Under 5044.7%
65 and up8.3%
All ages13.5%
Source: NCI SEER Database


According to the Centers for Disease Control and Prevention (CDC), mesothelioma affects white people more than any other race. From 1999 to 2015, nearly 95% of all people who died in the U.S. due to mesothelioma were white.

White patients also have the lowest survival rates out of any race, as noted by the NCI.

Race5-Year Survival Rate
Asian or Pacific Islander16%

Mesothelioma Survival Rates After Treatment

Patients may be able to live much longer and defy average survival rates with treatment from mesothelioma doctors.

Common mesothelioma treatment plans include surgery, chemotherapy, radiation, and other therapies.

Mesothelioma Survival Rate After Surgery

Mesothelioma surgery removes cancer tumors from the body. Different types of surgery can be used. Learn about mesothelioma surgery survival rates below.

  • Cytoreduction with HIPEC: Used to fight peritoneal mesothelioma, this treatment combines heated chemotherapy and abdominal surgery. Patients who receive cytoreductive surgery with HIPEC have 5-year survival rates ranging from 36% to 53%, according to a 2022 review of various studies published by the Journal of Clinical Medicine.
  • Extrapleural pneumonectomy (EPP): This surgery treats pleural mesothelioma and allows doctors to remove the lung closest to the cancer and as many cancer tumors as possible. When combined with radiation, patients who received an EPP had a 2-year survival rate of 21%, according to a 2020 study conducted by Mayo Clinic researchers.
  • Pleurectomy with decortication (P/D): Also used to treat pleural mesothelioma, doctors remove the lung lining and all the cancer they can see but spare both lungs. As a result, patients typically recover with fewer side effects. The 5-year survival rate for epithelial mesothelioma patients who undergo this surgery is 29%, according to a 2021 Journal of Thoracic Disease study.
Did You Know?

Mesothelioma Hope can help you find treatment at top cancer centers in your area. Use our Free Mesothelioma Doctor Match to get started.

Chemotherapy and Mesothelioma Survival Rate

Chemotherapy treatments are cancer-killing drugs that doctors administer. Chemotherapy can greatly improve survival rates of malignant mesothelioma when used alone or with other treatments.

Pleural mesothelioma patients had a 2-year survival rate of about 27% when treated with chemotherapy alone, according to a 2020 OncLive report.

Further, a 2022 report from the Journal of Clinical Haematology found that the 5-year survival rate of peritoneal mesothelioma patients was 80% if they were treated using cytoreduction with HIPEC and follow-up chemotherapy.

SMART: Surgery for Mesothelioma After Radiation Therapy

Some pleural mesothelioma patients receive a high dose of intensity-modulated radiation therapy (IMRT) followed by an EPP through the SMART approach.

Clinical studies have found that this procedure significantly improved survival rates compared to a surgery-first approach.

For example, epithelial pleural mesothelioma patients treated with SMART had a 42% 5-year survival rate, according to a Journal of Thoracic and Cardiovascular Surgery study from 2020.

Mesothelioma Survival Rates Without Treatment

Survival rates for patients who do not undergo treatment are low, as the cancer will continue to spread if left untreated.

For example, a 2023 Cancer Medicine study found that pleural mesothelioma patients who didn’t get surgery had a 5-year survival rate of only 5%. The survival rate more than tripled to 16% among patients who did get surgery.

Remember: Seeking treatment is the best way to outlive your survival rate. Our team can help you access top mesothelioma treatments at the best cancer centers in the country. Contact us to get started.

Stories of Mesothelioma Survivors

In some cases, patients with a poor mesothelioma prognosis and a low chance of survival have gone on to live for many years after their diagnosis. These patients are known as mesothelioma survivors.

Read about mesothelioma survivors who beat the odds and outlived the typical survival rates.

John's Story

  • Diagnosis: Pleural mesothelioma
  • Year of Diagnosis: 2019
  • Treatment: Chemotherapy

John Stahl was diagnosed in 2019 with stage 4 pleural mesothelioma after working around asbestos in the construction business for decades.

Stage 4 mesothelioma survival rates are low, with most people only living a few months. John, however, has lived for years and even returned to playing golf and riding offroad vehicles with his wife.

“It’s gonna end my life eventually, but I’m gonna live it as well as I can.”

- John Stahl, Stage 4 Pleural Mesothelioma Survivor

Julie's Story

  • Diagnosis: Peritoneal mesothelioma
  • Year of Diagnosis: 2006
  • Treatment: Chemotherapy and cytoreduction with HIPEC

Julie Gundlach received a shocking peritoneal mesothelioma diagnosis just after losing her father to asbestos-caused lung cancer. He was an electrician who worked with asbestos products and inadvertently exposed her in her childhood.

Julie was only in her 30s when she was diagnosed and given 6-12 months to survive. But, after undergoing a wide range of treatments, her cancer is now stable. This means it’s no longer spreading.

“My biggest fear was that my daughter would grow up and not remember her mother.”

- Julie Gundlach, Peritoneal Mesothelioma Survivor

Arthur's Story

  • Diagnosis: Pleural mesothelioma
  • Year of Diagnosis: 2018
  • Treatment: Chemotherapy, immunotherapy, and complementary and alternative medicine (CAM)

Arthur “Art” Putt first complained of shortness of breath and breathing troubles in early 2018. Following tests, Art’s mesothelioma doctors confirmed that he had pleural mesothelioma.

Originally given 6 months to live, Art proved his doctors wrong by undergoing mesothelioma treatments and following a nutrient-rich cancer diet.

“Get as close to the people in your family and friends as you can. Stay positive and keep a positive attitude.”

- Art Putt, Pleural Mesothelioma Survivor

In Memoriam: Mary Jane's Story

  • Diagnosis: Pleural mesothelioma
  • Year of Diagnosis: 2003
  • Treatment: Chemotherapy, radiation therapy, and surgery

After suffering from abdominal swelling and weight loss symptoms, Mary Jane Williams was diagnosed with peritoneal mesothelioma and given just 8 months to live.

She and her husband took 43 trips from their home state of Ohio to New York so she could undergo lifesaving treatments at top cancer centers, and their efforts paid off. Mary Jane lived with mesothelioma for 15 years before passing away from Alzheimer’s in 2018.

“I’m too young to die. And I just decided it was not going to beat me.”

- Mary Jane Williams, Peritoneal Mesothelioma Survivor

Read 7 inspiring stories of mesothelioma survivors and their families in our Free Survivors Guide.

Mesothelioma Survivors Guide
Get Your Free Survivors Guide
  • Survivors who beat the odds
  • Tips for fighting mesothelioma
  • Navigating life after treatment

Get It Shipped Overnight

Improve Your Mesothelioma Survival Rate

A survival rate can give you a better idea of your prognosis but does not define how long you may live after your diagnosis.

Treatment options like surgery, chemotherapy, radiation, and participation in clinical trials can possibly help you live longer. Further, mesothelioma cancer survival rates are improving with new advancements in treatment.

Mesothelioma Hope and our nursing support team have been helping cancer patients access top doctors, treatments, and financial aid for over 20 years. Learn about other patients we’ve helped in our Free Mesothelioma Survivors Guide.

Mesothelioma Survival Rate FAQs

What are the odds of beating mesothelioma?

The odds of fully beating mesothelioma are somewhat low, but that being said, some patients have lived for 20 years or more.

The 5-year survival rate of mesothelioma is 12%. This means 12% of patients will still be alive 5 years after being diagnosed. Still, some patients are able to live longer with medical treatment.

Is mesothelioma rarely fatal?

Mesothelioma is considered a terminal cancer, but some patients survive for decades with treatment. Several treatment options — such as chemotherapy, surgery, and radiation — can improve a patient’s survival rate for mesothelioma.

These treatments aim to kill cancer cells to prevent the spread of the disease. Without treatment, it’s very unlikely that you’ll outlive the average mesothelioma survival rate.

Can you survive mesothelioma?

Possibly, yes. Some people do survive mesothelioma.

Factors such as available treatments, age, mesothelioma cell type, and the type of mesothelioma can affect an individual’s survival rate.

However, patients who forgo mesothelioma treatment have a lower chance of surviving mesothelioma.

How long can you live with mesothelioma without treatment?

Pleural mesothelioma has an average life expectancy of 4 to 12 months without treatment, based on a Cancer Therapy Advisor report.

According to a 2020 study in Translational Lung Cancer Research, the median overall survival of peritoneal mesothelioma without treatment is 6 months to 1 year.

Is mesothelioma always fatal?

No. Some patients can go on to become long-term mesothelioma survivors — even though average survival rates are often poor.

You have the best chance of living past your projected survival rate by getting treatment.

Can mesothelioma be cured if caught early?

There’s no official cure for mesothelioma, but patients who are diagnosed in an early stage have a better chance of living past the average survival rates and life expectancies.

This is because doctors will often be able to remove most of the cancer through major treatments like surgery, chemotherapy, and/or radiation.

Dr. Mark LevinReviewed by:Mark Levin, MD

Certified Oncologist and Hematologist

  • Fact-Checked
  • Editor

Mark Levin, MD, has over 30 years of experience in academic and community hematology and oncology. In addition to serving as Chief or Director at four different teaching institutions throughout his life, he is still a practicing clinician, has taught and designed formal education programs, and has authored numerous publications in various fields related to hematology and oncology.

Dr. Mark Levin is an independently paid medical reviewer.

  • Board Certified Oncologist
  • 30+ Years Experience
  • Published Medical Author
Jenna TozziWritten by:

Director of Patient Advocacy

Jenna Tozzi, RN, is the Director of Patient Advocacy at Mesothelioma Hope. With more than 15 years of experience as an adult and pediatric oncology nurse navigator, Jenna provides exceptional guidance and support to mesothelioma patients and their loved ones. Jenna has been featured in Oncology Nursing News and is a member of the Academy of Oncology Nurse & Patient Navigators & the American Nurses Association.

Our Promise to You
Our Promise to You
  1. Abramson Cancer Center. (n.d.). Prognosis. Retrieved February 5, 2024, from
  2. American Cancer Society. (2018, November 16). Malignant Mesothelioma Stages. Retrieved February 5, 2024, from
  3. American Cancer Society. (2023, March 2). Survival rates for mesothelioma. Retrieved February 5, 2024, from
  4. American Society of Clinical Oncology. (March 2023). Mesothelioma: Statistics. Retrieved February 5, 2024, from
  5. Bou-Samra, P., Chang, A., et al. (2023, April 16). Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database. Retrieved February 5, 2024, from
  6. Breda, C., Furia, S., et al. (November 2021). Long-term outcomes after lung-sparing surgery for epithelial mesothelioma. Retrieved February 5, 2024, from
  7. Breen, W., Garces, Y., et al. (November 2020). Adjuvant Radiation Therapy for Pleural Mesothelioma after Extrapleural Pneumonectomy (EPP) or Pleurectomy and Decortication (P+D). Retrieved February 5, 2024, from
  8. Brydges, H., Yin, K., Balasubramaniyan, R., Lawrence, K., Rongkui, L., & Et al. (Autumn 2022). Primary Pericardial Mesothelioma: A Population-Based Propensity Score-Matched Analysis. Retrieved February 5, 2024, from
  9. Casiraghi, M., Maisonneuve, P., & Et al. (2017, May 8). Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma. Retrieved February 5, 2024, from
  10. Centers for Disease Control and Prevention. (2017, August 01). Malignant mesothelioma mortality – United States, 1999–2015. Retrieved February 5, 2024, from
  11. University of Maryland. (n.d.). Cytoreductive surgery and HIPEC — FAQs. Retrieved February 5, 2024, from
  12. De Perrot, M., Wu, L., et al. (May 2020). Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma. Retrieved February 5, 2024, from
  13. Enomoto, L., Shen, P., Levine, E., & Votanopoulos, K. (2019, May 7). Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: Patient selection and special considerations. Retrieved February 5, 2024, from
  14. Faig, J., Howard, S., Levine, E., Casselman, G., Hesdorffer, M., & Ohar, J. (2015, March 3). Changing pattern in malignant mesothelioma survival. Retrieved February 5, 2024, from
  15. Godar, M., Liu, J., Zhang, P., Xia, Y., & Yuan, Q. (2013). Primary pericardial mesothelioma: A rare entity. Retrieved February 5, 2024, from
  16. Kai, Y., Tsutani, Y., Tsubokawa, N., Ito, M., Mimura, T., Miyata, Y., & Okada, M. (March 2019). Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma. Retrieved February 5, 2024, from
  17. Kang, M., Lee, S., Kwon, S., Huh, D., & Lee, Y. (2021, October 18). Survival of Korean patients with malignant pleural mesothelioma compensated for the Asbestos Injury Relief. Retrieved February 5, 2024, from
  18. Kheir, F. (2019, January 17). Pleural plaques/mesothelioma. Retrieved February 5, 2024, from
  19. Kim, J., Bhagwandin, S., & Labow, D. (June 2017). Malignant peritoneal mesothelioma: A review. Retrieved February 5, 2024, from
  20. Li, C., Kennedy, T., & Alexander, H.R. (2022, March 21). Treatment of Patients with Malignant Peritoneal Mesothelioma. Retrieved February 5, 2024, from
  21. Moffitt Cancer Center. (n.d.). Mesothelioma Survival Rate. Retrieved February 5, 2024, from
  22. National Cancer Institute. (n.d.). SEER Explorer: Mesothelioma. Retrieved February 5, 2024, from
  23. Nazemi, A., Nassiri, N., & Pearce, S. (2019, April). Testicular mesothelioma: An analysis of epidemiology, patient outcomes, and prognostic factors. Retrieved February 5, 2024, from
  24. Oliveira, G., Al-Kindi, S., Hoimes, C., & Park, S. (2015, October 14). Characteristics and survival of malignant cardiac tumors. Retrieved February 5, 2024, from
  25. Shah, R., Klotz, L., & Glade, J. (2022, February 18). Current management and future perspective in pleural mesothelioma. Retrieved February 5, 2024, from
  26. Strauss, A. (2017, May 10). Still defying the odds after 20 years. Retrieved February 5, 2024, from
  27. Sugarbaker, P. H. (2022, April 12). Long-term Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma. Retrieved February 5, 2024, from
  28. Thomas, A., Chen, Y., Yu, T., Gill, A., & Prasad, V. (2015, June 30). Distinctive clinical characteristics of malignant mesothelioma in young patients. Retrieved February 5, 2024, from
  29. Van Oudheusden, T., Braam, H., Luyer, M., Wiezer, M., Van Ramshorst, B., Nienhuijs, S., & De Hingh, I. (April 2015). Peritoneal cancer patients not suitable For cytoreductive surgery and HIPEC during Explorative surgery: Risk Factors, treatment options, and prognosis. Retrieved February 5, 2024, from
  30. Virgil, H. (2020, August 10). Nivolumab/ipilimumab significantly improves OS in malignant pleural mesothelioma. Retrieved February 5, 2024, from
How We Can Help

Mesothelioma Hope is passionate about helping patients and families affected by this aggressive cancer. A mesothelioma diagnosis can be scary and isolating, but we’re here for you at every step. Hope is only a phone call away.

(866) 608-8933
Medical Guidance
  • Get a second opinion
  • Find a doctor or cancer center
  • Access clinical trials
  • Improve your quality of life
Financial Assistance
  • Access $30 billion in trust funds
  • File a mesothelioma claim
  • Increase your VA benefits
  • Apply for travel grants
Supportive Care
  • Find a support group or peer mentor
  • Get help with daily tasks
  • Explore respite care options
  • Navigate life post-treatment